Pharmabiz1h
GS1 India hosts healthcare conference on ‘Navigating the Future of Healthcare’
GS1 India, a supply chain standards organization set up under the ministry of commerce, Government of India, hosted the ...
Pharmabiz4h
BD expands capacity for advanced prefillable syringes and enhances injection experience for next generation of biologics
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the commercial release of the BD ...
Pharmabiz4h
EMA’s human medicines committee elects Bruno Sepodes as new chair
EMA’s human medicines committee elects Bruno Sepodes as new chair: Amsterdam, The Netherlands Friday, September 20, 2024, ...
Pharmabiz1h
InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP-248 for acute myeloid leukaemia
InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP-248 for acute myeloid leukaemia: Beijing Friday, September 20, 2024, 18:00 Hrs [IST] InnoCare Pharma ...
Pharmabiz1h
SciSparc submits IND application to US FDA for phase IIb trial for Tourette syndrome
SciSparc submits IND application to US FDA for phase IIb trial for Tourette syndrome: Tel Aviv, Israel Friday, September 20, 2024, 17:30 Hrs [IST] SciSparc Ltd., a specialty clini ...
Pharmabiz2h
Laurentis inks MoU with Colibri Isotopes to carry out isotopes irradiation services
Laurentis inks MoU with Colibri Isotopes to carry out isotopes irradiation services: Clarington Friday, September 20, 2024, 17:00 Hrs [IST] Laurentis Energy Partners (Laurentis) a ...
Pharmabiz2h
Experts urge immediate action against the growing health crisis on World Alzheimer’s Day
Experts urge immediate action against the growing health crisis on World Alzheimer’s Day: Our Bureau, Mumbai Friday, September 20, 2024, 16:45 Hrs [IST] On the occasion of World ...
Pharmabiz5h
ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration
ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration: Vancouver, British Columbia Friday, September 20, 2024, 14:00 Hrs [IST] ME ...
Pharmabiz7h
New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients
New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...
Pharmabiz6h
Organon to buy Dermavant Sciences including its innovative dermatologic therapy, Vtama cream 1% to treat plaque psoriasis
Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...
Pharmabiz6h
Neuberg Diagnostics launches personalized genomics platform, “Geniee-Decode your DNA”
Neuberg Diagnostics, a global leader in cutting-edge healthcare diagnostics, has officially launched its groundbreaking personalized genomics platform, “Geniee-Decode your DNA”. The launch signifies a ...
Pharmabiz10h
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc ...